A plasma-ratio search identifies exploratory Alzheimer case-label associations
Source check: Source checked. Not independent scientific confirmation.
Finding: An SVM-guided search selected plasma-protein ratios associated with Alzheimer case labels in 60 stored donor samples. Candidate combinations included KYNU/MSR1, NCAN/PRTG and IL-5Rα/GFRα-1. The groups differed in average age by about 13 years, and the search reused the evaluation data; this is not independent diagnostic validation.
Technology: Linear support vector machine; feature-subset search
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Linear SVM classification and exhaustive/forward subset search select protein ratios for separating donor-group labels; the learned selection enables the represented candidate associations.
- Test and result
- The reanalysis used 38 control and22 Alzheimer-labeled samples, with82 protein measurements generating6,642 ordered ratios. Leave-one-out scores informed selection of best subsets; observed selected-ratio differences were then examined in the same samples.
- Limitation / still unknown
- Feature search and hyperparameter selection reused the LOOCV results, so headline98–100percent separation is selection-informed and not a new independent test. Mean ages were66.5 versus79.7; adding age as another classifier input does not adjust that confounding. The source also mixes22 and23 disease-sample denominators in some results. This is a reanalysis of previously collected data, without new assays, causal protein interactions or demonstrated clinical utility.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC11840181/ · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC11840181/unicode
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 21 Nov 2026. Review scope: Official primary BioC original article sections: Clinical donor metadata;preprocessing;SVM and global feature search;ratio Results and age analysis; no laboratory-method validation.
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 1/5 · Validation 2/5 · Novelty 1/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.